BBLG

Bone Biologics
BBLG

7 hedge funds and large institutions have $36.7K invested in Bone Biologics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$30.8K
2
+$3.53K
3
+$642
4
Citigroup
Citigroup
New York
+$575
5
Bank of America
Bank of America
North Carolina
+$28

Top Sellers

1
-$131
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$30.8K
TRCT
2
Tower Research Capital (TRC)
New York
$4.08K
SS
3
SBI Securities
Japan
$642
Citigroup
4
Citigroup
New York
$575
CS
5
Clear Street
New York
$385
UBS Group
6
UBS Group
Switzerland
$184
Bank of America
7
Bank of America
North Carolina
$39